CrossBridge Bio logo

CrossBridge Bio

CrossBridge Bio operates as a biotechnology company, innovates ADC therapeutics through stable dual linker payload technology.

crossbridgebio.com

Company Details

Founded

2023

Employees

Between 5 - 10 employees

Raised

$10,000,000

Public

No

Acquired

No

CEO

Michael TorresMichael Torres

Founders

Michael Torres
Michael Torres

Company Collections

These are collections CrossBridge Bio is a part of. Click on the collection name to view similar companies.

Total Amount Raised: $10,000,000

CrossBridge Bio Funding Rounds

  • Seed

    $10,000,000

    Seed Investors

    CE-Ventures
    TMC Venture Fund
    Portal Innovations
    Alexandria Real Estate Equities
    Linden Lake Ventures
Funding info provided by Diffbot.

CrossBridge Bio Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on CrossBridge Bio.

Recent reviews